News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

T2 Biosystems Announces Issuance of Patents Covering Components of the T2Dx Direct Detection Device



1/29/2013 9:46:30 AM

LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued two design patents covering components of the T2Dx direct detection device. These patents, USD673,293 and USD674,112, describe cartridge designs for the Company’s T2Candida assay, which is run on the T2Dx platform. T2Candida is a whole blood diagnostic test for the rapid detection of five species of Candida, a fungal pathogen associated with sepsis and the fourth leading hospital acquired infection in the United States.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES